Treatment of Hypomagnesemia
For life-threatening hypomagnesemia with cardiotoxicity or cardiac arrest, administer IV magnesium sulfate 1-2 g as a bolus IV push immediately. 1
Emergency/Critical Situations
Cardiac Arrest or Severe Arrhythmias
- Administer 1-2 g magnesium sulfate IV push for cardiac arrest or severe cardiotoxicity associated with hypomagnesemia (Class I recommendation) 1
- This is particularly critical for polymorphic ventricular tachycardia and torsades de pointes 1
Torsades de Pointes with QT Prolongation
- Give IV magnesium sulfate even if serum magnesium levels are normal, as this suppresses the arrhythmia 1
- Replete magnesium to ≥2.0 mmol/L in patients with acquired QT prolongation and recurrent torsades 1
- If IV magnesium fails to suppress recurrent episodes, increase heart rate with atrial/ventricular pacing or isoproterenol 1
Non-Emergency Inpatient Management
Moderate to Severe Hypomagnesemia (<0.5 mmol/L or symptomatic)
- Parenteral magnesium is indicated when serum magnesium is below 0.5 mmol/L or when symptoms are present (Chvostek/Trousseau signs, paresthesias, tremor, convulsions) 2
- Administer IV or subcutaneous magnesium sulfate 1
- For patients requiring frequent supplementation, use IV administration through a tunneled central line 1
- Add 4-12 mmol magnesium sulfate to saline bags for combined fluid and magnesium replacement 1
Mild to Moderate Hypomagnesemia (0.5-0.7 mmol/L)
- Oral magnesium supplementation is appropriate for asymptomatic patients with levels between 0.5-0.7 mmol/L 2
- Use magnesium oxide 12-24 mmol daily (given as 4 mmol capsules) 1
- Administer at night when intestinal transit is slowest to maximize absorption 1
Outpatient/Chronic Management
First-Line Oral Therapy
- Magnesium oxide is the preferred oral formulation as it contains the most elemental magnesium and is converted to magnesium chloride in the stomach 1
- Start with 12 mmol magnesium oxide at night, titrating up to 24 mmol daily as needed 1
- Note that most oral magnesium salts are poorly absorbed and may worsen diarrhea 1
Refractory Cases
If oral magnesium fails to normalize levels:
- Add oral 1-alpha hydroxycholecalciferol starting at 0.25 mg daily, increasing every 2-4 weeks up to 9.0 mg daily 1
- Monitor serum calcium regularly to avoid hypercalcemia 1
- Consider IV or subcutaneous magnesium infusions (e.g., 2 g infused over 2 hours every 2-3 weeks) 1
Special Populations
Short Bowel/Malabsorption Patients:
- First correct water and sodium depletion to address secondary hyperaldosteronism, which is the most important initial step 1
- Reduce/avoid excess dietary lipid 1
- Follow the stepwise approach: rehydration → oral magnesium → 1-alpha cholecalciferol → parenteral magnesium 1
Patients on Continuous Renal Replacement Therapy:
- Use dialysis solutions containing magnesium to prevent KRT-related hypomagnesemia 1
- This is particularly important with regional citrate anticoagulation, which chelates ionized magnesium and increases losses 1
- Prevention through modified dialysate is preferred over exogenous supplementation 1
Cancer Patients:
- Magnesium replacement is recommended for chemotherapy-induced hypomagnesemia (cisplatin, cetuximab) 1
- Use IV magnesium sulfate to reverse neurological symptoms including confusion, hallucinations, irritability, nystagmus, and seizures 1
Important Caveats
Monitoring Requirements
- For drugs causing "significant" hypomagnesemia (cisplatin, amphotericin B, cyclosporine): routine magnesium monitoring is warranted 3
- For "potentially significant" drugs (aminoglycosides, tacrolimus, carboplatin): monitor when symptoms present, persistent hypokalemia/hypocalcemia exists, or multiple hypomagnesemic drugs are used 3
Dose Adjustments
- Reduce magnesium dose in renal insufficiency to avoid hypermagnesemia 2
- Lower dose if constipation develops 2
- Avoid oral antacids containing magnesium in hypophosphatemia 2